scholarly journals Differential effects of interleukin 6 and lipopolysaccharide on teleost B lymphocytes

2016 ◽  
Vol 53 ◽  
pp. 72 ◽  
Author(s):  
Beatriz Abós ◽  
Tiehui Wang ◽  
Rosario Castro ◽  
Esther Leal ◽  
Alfonso Luque ◽  
...  
1989 ◽  
Vol 170 (4) ◽  
pp. 1463-1468 ◽  
Author(s):  
E B Smeland ◽  
H K Blomhoff ◽  
S Funderud ◽  
M R Shalaby ◽  
T Espevik

In this paper we have shown that extensively purified human B lymphocytes respond to IL-4 treatment with a marked production of IL-6. Addition of anti-mu potentiated the effect of IL-4 on IL-6 production. Other cytokines tested like TNF-alpha and-beta, IFN-gamma, IL-1, IL-2, and IL-5 did not induce IL-6 secretion when given to resting B cells. Although B cells generally also produced TNF-alpha and TNF-beta upon stimulation, IL-4 did not induce TNF secretion and seemingly had a specific effect on IL-6 production.


Shock ◽  
1997 ◽  
Vol 7 (5) ◽  
pp. 324-331 ◽  
Author(s):  
Alicia M. Mohr ◽  
Jeffrey S. Upperman ◽  
Rashmi Taneja ◽  
Ming T. Wang ◽  
Pranela Rameshwar ◽  
...  

1993 ◽  
Vol 47 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Nitza Lahat ◽  
Ariel Miller ◽  
Relly Shtiller ◽  
Ellias Touby

2009 ◽  
Vol 60 (5) ◽  
pp. 1261-1271 ◽  
Author(s):  
Caroline Rochas ◽  
Sophie Hillion ◽  
Alain Saraux ◽  
Rizgar A. Mageed ◽  
Pierre Youinou ◽  
...  

2006 ◽  
Vol 13 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Erik L. Munson ◽  
Dean T. Nardelli ◽  
K. H. Kevin Luk ◽  
Monica C. Remington ◽  
Steven M. Callister ◽  
...  

ABSTRACT Determination of the immunological mediators responsible for promoting the production of borreliacidal antibody may facilitate the development of an improved borreliosis vaccine for human and veterinary use. Previously, we developed an in vitro assay to determine if borreliacidal antibody production could be augmented by treatment with different cytokines. In this study, in vitro treatment of lymph node cells producing borreliacidal antibody with recombinant interleukin-6 (rIL-6) resulted in a fourfold enhancement of anti-OspA borreliacidal antibody. Moreover, rIL-6 enhanced Western immunoblot titers and increased the number of B lymphocytes. In contrast, treatment of anti-OspA borreliacidal antibody-producing cells with anti-IL-6 resulted in a fourfold reduction in borreliacidal activity. Treatment with anti-IL-6 also inhibited enhanced borreliacidal antibody production induced by anti-gamma interferon. These data suggest that IL-6 plays a significant role in the production of anti-OspA borreliacidal antibodies.


1990 ◽  
Vol 20 (11) ◽  
pp. 2389-2393 ◽  
Author(s):  
Yves Levy ◽  
Jean-Paul Fermand ◽  
Jean-Claude Brouet

1983 ◽  
Vol 71 (1) ◽  
pp. 163
Author(s):  
A LATIKAINEN ◽  
G DELESPESSE ◽  
Y YANAGIHAR ◽  
A SEHON

1999 ◽  
Vol 9 (5) ◽  
pp. 405-415 ◽  
Author(s):  
B.M.L. VERBURG-VAN KEMENADE ◽  
B. NOWAK ◽  
M.Y. ENGELSMA ◽  
F.A.A. WEYTS

Sign in / Sign up

Export Citation Format

Share Document